![Epidemiology / Medical statistics / Clinical research / Design of experiments / Imiquimod / Actinic keratosis / Squamous-cell carcinoma / Clinical trial / Cutaneous leishmaniasis / Medicine / Health / Pharmacology Epidemiology / Medical statistics / Clinical research / Design of experiments / Imiquimod / Actinic keratosis / Squamous-cell carcinoma / Clinical trial / Cutaneous leishmaniasis / Medicine / Health / Pharmacology](https://www.pdfsearch.io/img/6649a0130f8f75a8868a25f6fd8deb6e.jpg)
| Document Date: 2014-10-01 21:56:22 Open Document File Size: 94,16 KBShare Result on Facebook
City Trial / / Company LEO Pharma Pty Ltd / / Country Australia / / Currency USD / / Event FDA Phase / / IndustryTerm treatment algorithm / / MedicalCondition inflammatory response / keratoses / Actinic Keratosis / clinically evident solar keratosis / solar keratoses / squamous cell carcinoma / Treat Actinic Keratoses / solar keratosis / actinic keratoses / / Organization American Academy of Dermatology / Listing Requested and PBAC’s View Authority / / Person Ingenol / / Position representative / Trial ID/ First Protocol title/ Publication title author / / Product fluorouracil / SK Ingenol / PEP0055 / PEP005 / SK / PEP005-015 / PEP00559 / / ProvinceOrState Saskatchewan / / PublishedMedium Archives of Dermatology / British Journal of Dermatology / / Technology treatment algorithm / /
SocialTag |